Izindaba
Exchange rate hurting chronic drug suppliers – but ARV pipeline safe, says govt
Abstract
The government has categorically denied that there is any danger of antiretroviral (ARV) drug supplies running short or drying up following a claim from one of their three suppliers, Aspen Pharmaceuticals, that insufficient relief on the dismal rand exchange rate and single exit price (SEP) is creating a net loss.
Author's affiliations
Chris Bateman, HMPG, South Africa
Full Text
PDF (103KB)Keywords
Cite this article
Article History
Date published: 2014-06-10
Article Views
Full text views: 1058
Comments on this article
*Read our policy for posting comments here